Summary
The effect of nomifensin (Hoechst 36984), a synthetic psychotropic drug whose structure differs from MAO inhibitors and tricyclics, was studied in a double blind comparative trial with desimipramine in patients with various depressive syndromes. Forty-three patients (23 in the nomifensin group and 20 in the desimipramine group) were studied for 6 weeks. Clinical follow-up was done with the Wittenborn scale (WPRS), Hamilton's rating scale for depression (HRS), Zung's scale (SDS), and the PEN inventory. The average daily dose was nomifensin 84 mg and desimipramine 76 mg. Changes in HRS, WPRS and SDS showed statistically significant improvement with both treatments. A moderate anxiolytic effect was found in the nomifensin group, whereas medication had to be discontinued in two desimipramine-treated patients because of its drive-enhancing effect. Urinary phenylethylamine excretion rose in 2 out of 8 patients after 5 weeks of treatment with nomifensin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hoffmann, I., Erhart, G., Schmitt, K.: 8-Amino-4 phenyl-1,2,3,4, tetrahydroisoquinoline, eine neue Gruppe antidepressiver Psychopharmaka. Arzneimittel-Forsch.21, 1045 (1971)
Hoffmann, I.: 8-Amino-4 methyl-1-4 phenyl-1,2,3,4 tetrahydroisoquinoline, a new antidepressant. Arzneimittel-Forsch.23, 45–50 (1973)
Hunt, P., Kannengiesser, M.H. Raynaud, J.P.: Nomifensine: A new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J. Pharm. Pharmacol.26, 370–371 (1974)
Angst, J., Koukkou, M., Bleuler Herzog, M., Martens, H.: Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin. Archiv Psychiatr. Nervenkrank.219, 265–276 (1974)
Fischer, E., Heller, B., Spatz, H., Reggiani, H.: Thin layer chromatographic assay of phenetylamine content of the rat brain and its changes after reserpine and imipramine administration. Arzneimittel-Forsch.22, 1560 (1972)
Fischer E., Spatz, H., Heller, B., Reggiani, H.: Phenethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration. Experientia28, 307–308 (1972)
WHO International Classification of Diseases. Manual diagnóstico y estadístico de trastornos mentales. Buenos Aires: Acta Fondo para la Salud Mental 1969
Manual for the ECDEU Assessment Battery. Psychopharmacology Research Branch. Maryland: National Institute of Mental Health, second revision 1970
Eysenck, S.B.G., Eysenck, H.J.: Scores on three personality variables as a function of age, sex and social class. Brit. J. Soc. clin. Psychol.8, 69–76 (1969)
Zung, W.W.K.: Depression in the normal aged. Psychosom.3, 287–292 (1967)
Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat.23, 56–62 (1960)
Franchini, E.A.: Ensaio clinico en 30 pacientes de una nova medicacao antidepresiva: Nomifensin. Rev. Brasil. Clin. Terapeut.2, 317–322 (1973)
Moizeszowicz, J.: Actualización en la evaluación clínica de psicofármacos. Acta Psiquiát. Psicológ. América Lat.21, 41–51 (1975)
Sabelli, H.C., Monaim, A.D.: Phenylethylamine hypothesis of affective behaviour. Amer. J. Psychiat.131, 695–699 (1975)
Costall, B., Kelly, D.M., Naylor, R.J.: Nomifensin: A potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia (Berl.)41, 153–164 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Acébal, E., Subirá, S., Spatz, J. et al. A double blind comparative trial of nomifensin and desimipramine in depression. Eur J Clin Pharmacol 10, 109–113 (1976). https://doi.org/10.1007/BF00609468
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609468